Generation of a PDGFRB-mCherry knock-in reporter human induced pluripotent stem cell line (KITi001-A-1), using CRISPR/Cas9 nuclease

被引：1

作者：

Jo, Seongyea ^{[1
,2
]}

Kim, Ji-Woo ^{[1
]}

Noh, Haneul ^{[1
]}

Kim, Hyemin ^{[1
]}

Kim, Jong-Hoon ^{[2
]}

Park, Han-Jin ^{[1
]}

机构：

[1] Korea Inst Toxicol, Dept Predict Toxicol, Daejeon, South Korea

[2] Korea Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Lab Stem Cells & Tissue Regenerat, Seoul, South Korea

来源：

STEM CELL RESEARCH | 2023年 / 69卷

关键词：

D O I：

10.1016/j.scr.2023.103081

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

PDGFRB encodes platelet-derived growth factor receptor beta (PDGFR-beta), a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. It is required for the normal development of the vascular and nervous systems and rearrangement of the actin cytoskeleton. PDGFR-beta plays an essential role in early liver diseases, including liver fibrosis. Here, we generated a human induced pluripotent stem cell (iPSC) line, KITi001-A-1, using CRISPR/Cas9. This reporter iPSC line and its derivatives are useful for tracing PDGFR-beta-expressing cells and for screening for liver fibrosis-inducing compounds.

引用

页数：6

共 50 条

[21] Generation of a tdTomato-GAD67 reporter human epilepsia mutation induced pluripotent stem cell line, USTCi001-A-2, using CRISPR/Cas9 editing
Zhao, Huifang
He, Lang
Huang, Hualin
Li, Shuai
Cheng, Na
Tang, Feng
Han, Xiaobo
Lin, Zuoxian
Huang, Rongqi
Zhou, Peng
Deng, Sihao
Huang, Jufang
Li, Zhiyuan
STEM CELL RESEARCH, 2020, 48
[22] Generation of three TTN knock-out human induced pluripotent stem cell lines using CRISPR/Cas9 system
Kang, Ji -Young
Mun, Dasom
Chun, Yumin
Park, Da -Seul
Kim, Hyoeun
Yun, Nuri
Lee, Seung-Hyun
Joung, Boyoung
STEM CELL RESEARCH, 2022, 64
[23] Generation of a NONO homozygous knockout human induced pluripotent stem cell line by CRISPR/Cas9 editing
Yi, Tong
Bai, Rui
Sun, Hairui
Lan, Feng
Zhang, Hongjia
He, Yihua
STEM CELL RESEARCH, 2020, 47
[24] Generation of a CFTR knock-in reporter cell line (MHHi006-A-1) from a human induced pluripotent stem cell line
Engels, Lena
Olmer, Ruth
de la Roche, Jeanne
Goehring, Gudrun
Ulrich, Saskia
Haller, Ralf
Martin, Ulrich
Merkert, Sylvia
STEM CELL RESEARCH, 2019, 40
[25] Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9
Han, Hyeong-jun
Seo, Hyang-Hee
Han, Hyo-Won
Kim, Jung-Hyun
STEM CELL RESEARCH, 2019, 40
[26] Targeted Genome Editing of Human Induced Pluripotent Stem Cells Using CRISPR/CAS9 to Generate a Knock-in Type II Collagen Reporter for the Purification of Chondrogenic Cells
Adkar, Shaunak S.
Willard, Vincent P.
Brunger, Jonathan M.
Shiao, Kenneth T.
Gersbach, Charles A.
Guilak, Farshid
MOLECULAR THERAPY, 2016, 24 : S128 - S128
[27] Generation of OCT4-EGFP, NANOG-tdTomato dual reporter human induced pluripotent stem cell line, KKUi001-A, using the CRISPR/Cas9 system
Lee, Minseong
Choi, Na Young
Park, Soree
Bang, Jin Seok
Lee, Yukyeong
Jeong, Dahee
Ham, Seokbeom
Lim, Sohee
Kim, Kyun-Hwan
Ko, Kinarm
STEM CELL RESEARCH, 2020, 48
[28] Generation of a GFI1-flag knock-in human embryonic stem cell line using CRISPR-Cas9 technology
Kang, Baoqiang
Cong, Zhongyi
Duan, Jinyue
Liu, Kun
Wang, Yi
STEM CELL RESEARCH, 2022, 60
[29] Generation of FOXJ1-EGFP knock-in reporter human embryonic stem cell line, WAe001-A-2D, using CRISPR/Cas9-based gene targeting
Chen, Jingyi
Dai, Tiankai
Li, Qian
Xu, Tao
Zhang, Wei
Sun, Jiaqi
Liu, Huisheng
STEM CELL RESEARCH, 2024, 78
[30] Generation of induced pluripotent stem cell line carrying frameshift variants in NPHP1 (UCSFi001-A-68) using CRISPR/Cas9
Dyke, Emma
Bijnagte-Schoenmaker, Chantal
Wu, Ka Man
Oudakker, Astrid
Roepman, Ronald
Kasri, Nael Nadif
STEM CELL RESEARCH, 2023, 68

← 1 2 3 4 5 →